This handout is for acute weakness (ed workup — focal + generalized + fluctuating). Your care team identified this based on: focal weakness (hemiparesis / monoparesis / facial droop / dysarthria) — stroke until proven otherwise (powers aha/asa 2019 pmid 31662037; saver nejm 2019).
Other reasons your team may use this plan: generalized symmetric weakness, often ascending — gbs / myopathy / electrolyte / botulism (van den berg brighton gbs pmid 24163275); fatigable / fluctuating weakness + ptosis / diplopia / dysphagia / dysarthria — myasthenic crisis (sanders mgfa 2016 pmid 27358333); episodic / periodic paralysis — channelopathies (hypokalemic, hyperkalemic, thyrotoxic) — k-based phenotype.
Call 911 or go to the nearest emergency room right away if you have:
Stroke: secondary prevention (antiplatelet OR anticoag for AFib, statin, BP control, dysphagia screen, rehab); dual-antiplatelet for high-risk TIA (CHANCE/POINT). GBS: outpatient neuro + rehab. MG: chronic immunosuppression + crisis prevention. Cord/cauda: spine surgery + radiation; rehab. Rhabdo: cause workup + electrolyte monitoring. Channelopathy: chronic K replacement + trigger avoidance
Guideline: 2019 AHA/ASA Stroke Guideline (Powers) + 2018-19 DEFUSE-3/DAWN endovascular trials + 2014 van den Berg Brighton GBS + 2016 Sanders MGFA myasthenia + 2009 Bosch NEJM rhabdomyolysis + 2015 CDC Sobel botulism + 2015 Greenberg AAN transverse myelitis + 2015 Stroes EAS statin myopathy + 2007 Johnston Lancet ABCD2 + 2013 CHANCE / 2018 POINT DAPT for TIA